Assessment of QSant™ for Underlying Allograft Rejection
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNephroSant
About this trial
The AQUA registry is a multi-center observational study to assess the clinical management of kidney transplant recipients (KTRs) with use of the QSant test. QSant is a test based on 6 urinary biomarkers including cell-free DNA, that is used for the evaluation and management of acute rejection in renal allograft recipients with clinical suspicion of rejection, as well as subclinical rejection.
Eligibility criteria
Qualifiers
Kidney transplant recipient, ≤ 90 days post kidney transplant of any age, solitary or combined multi-organ solid transplants which includes a kidney transplant.
Able to understand risks and requirements of participation and provide informed consent
Willing and able to comply with the study requirements
Disqualifiers
Inability to provide a voided urine sample per collection protocol
Urological abnormalities such as augmented bladder, ileo-conduits, mitrofanoff, and vesicostomy.
Trial design
Treatments tested in this trial
- QSant-TM Urine Test
Treatment groups
4,000 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov